Startup, 2019 Undergraduate National Finals

Renovion is a pre-clinical stage pharmaceutical company with a therapy for chronic inflammatory airway diseases. Our goal is to be the first drug ever approved for patients that have received a bilateral lung transplant. After success in these patients, we want to help patients in other areas such as cystic fibrosis, asthma and chronic obstructive pulmonary disease (COPD).